Your browser doesn't support javascript.
loading
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study.
Sundström, Johan; Bodegard, Johan; Bollmann, Andreas; Vervloet, Marc G; Mark, Patrick B; Karasik, Avraham; Taveira-Gomes, Tiago; Botana, Manuel; Birkeland, Kåre I; Thuresson, Marcus; Jäger, Levy; Sood, Manish M; VanPottelbergh, Gijs; Tangri, Navdeep.
Affiliation
  • Sundström J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Bodegard J; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Bollmann A; Cardiovascular, Renal and Metabolism, Medical Department, BioPharmaceuticals, AstraZeneca, Oslo, Norway.
  • Vervloet MG; Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
  • Mark PB; Amsterdam UMC, Department of Nephrology, Amsterdam, the Netherlands.
  • Karasik A; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Taveira-Gomes T; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
  • Botana M; Department of Community Medicine, Information and Decision in Health, Faculty of Medicine, University of Porto, Portugal.
  • Birkeland KI; University Hospital Lucus Augusti, Lugo, Spain.
  • Thuresson M; Department of transplantation medicine, Oslo University Hospital, Oslo, Norway.
  • Jäger L; University of Oslo, Oslo, Norway.
  • Sood MM; Statisticon AB, Uppsala, Sweden.
  • VanPottelbergh G; Institute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
  • Tangri N; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Lancet Reg Health Eur ; 20: 100438, 2022 Sep.
Article in En | MEDLINE | ID: mdl-36090671

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Lancet Reg Health Eur Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Lancet Reg Health Eur Year: 2022 Document type: Article Affiliation country: Country of publication: